July 18, 2019
By uclahealth 
In 2015, ESPN reporter Holly Row was diagnosed with desmoplastic melanoma, a rare, fast-spreading form of skin cancer. After a first surgery, she enrolled in a UCLA clinical trial led by Dr. Antoni Ribas testing a new approach for advanced melanoma in which participants took the drug Keytruda (pembrolizumab) in combination with another immunotherapy drug […]
Tags: Antoni Ribas MD, cancer, clinical trials, featured, immunotherapy, keytruda, melanoma, UCLA Jonsson Comprehensive Cancer Center
June 7, 2016
Pembrolizumab (Keytruda®) Offers New Hope for Patients with Metastatic Melanoma
By uclahealth
In the summer of 2015, a brand-new cancer therapy known as “Jimmy Carter’s cancer drug” shot to fame. Called pembrolizumab, it was instrumental in former President Jimmy Carter’s successful treatment for metastatic melanoma. Previously, patients with metastatic melanoma (skin cancer that has spread to other areas of the body) could undergo a combination of treatment […]
Tags: cancer drug, chemotherapy, immune system, immunotherapy, keytruda, melanoma, metastatic melanoma, pembrolizumab, radiation therapy, skin cancer, skin diseases, surgery
